Sinomenine inhibits proliferation of SGC-7901 gastric adenocarcinoma cells via suppression of cyclooxygenase 2 expression

Oncology Letters

Volumn 2, Issue 4, 2011, Pages 741-745

  Yifei, L V ^a   Changshun, L I ^a   Shuang, L I ^a   Zhiming, Hao ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Cyclooxygenase 2; Gastric cancer; Sinomenine

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; MESSENGER RNA; SINOMENINE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MEDICINAL PLANT; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINOMENIUM; STOMACH ADENOCARCINOMA; WESTERN BLOTTING;

EID: 79958045512     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.305     Document Type: Article

References (29)

1. Ke XY, Yu MX and Jiang M: Clinical observation on treatment of rheumatoid arthritis with sinomenine. Bei Jing Yi Xue 8: 186-188, 1986.
2. Satoh H: Electropharmacology of sinomeni caulis et rhizome and its constituents in cardiomyocytes. Am J Chin Med 33: 967-979, 2005.
3. Vieregge B, Resch K and Kaever V: Synergistic effects of the alkaloid sinomenine in combination with the immunosuppressive drugs tacrolimus and mycophenolic acid. Planta Medica 65: 80-82, 1999.
4. Dai YB, Huang X and Luo ZG: Immunosuppressive effect of sinomenine on ICAM-1 expression in rat renal allograft rejection. Mod J Integr Trad Chin West Med 12: 1358-1363, 2003.
5. Chen W, Shen YD and Zhao GS: Inhibitory effect of sinomenine on expression of cyclooxygenase-2 in lipopolysaccharide-induced PC-12 cells. China J Chin Mat Medica 29: 900-903, 2004.
6. Zhang Y, Wu M and Li XG: Experimental study on the effect of selective COX-2 inhibitor sinomenine on HeLa cells. Prog Mod Biomed 6: 38-40, 2006.
7. Hla T, Bishop-Bailey D, Liu CH, Schaefers HJ and Trifan OC: Cyclooxygenase-1 and -2 isoenzymes. Int J Biochem Cell Biol 31: 551-557, 1999.
8. Morita I: Distinct functions of COX-1 and COX-2. Prostaglandins Other Lipid Mediat 68: 165-175, 2002.
9. Su JL, Shih JY, Yen ML, Jeng YM, Chang CC and Hsieh CY: Cyclooxygenase-2 induces EP1-and HER-2/Neu-dependent vascular endothelialgrowth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma. Cancer Res 64: 554-564, 2004.
10. Soumaoro LT, Uetake H, Higuchi T, Takagi Y, Enomoto M and Sugihara K: Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer. Clin Cancer Res 10: 8465-8471, 2004.
11. Tucker ON, Danneberg AJ and Tang EK: Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res 59: 987-990, 1999.
12. Timoshenko AV, Chakraborty C, Wagner GF and Lala PK: COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer. Br J Cancer 94: 1154-1163, 2006.
13. Meric JB, Rottey S, Olaussen K, Soria JC, Khayat D and Rixe O: Cyclooxygenase-2 as a target for anticancer drug development. Crit Rev Oncol Hematol 59: 51-64, 2006.
14. Dannenberg AJ and Subbaramaiah K: Targeting cyclooxygenase-2 in human neoplasia: rationale and promise. Cancer Cell 4: 431-436, 2003.
15. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics. CA Cancer J Clin 59: 225-249, 2009.
16. Wagner AD, Grothe W, Haerting J, et al: Combination chemotherapies in advanced gastric cancer: an updated systematic review and meta-analysis. American Society of Clinical Oncology 25: 4555, 2007.
17. Chen CN, Sung CT, Lin MT, Lee PH and Chang KJ: Clinicopathologic association of cyclooxygenase-1 and cyclooxygenase-2 expression in gastric adenocarcinoma. Ann Surg 233: 183-188, 2001.
18. Yamaca D, Ayyildiz T, Coskun U, et al: Cyclooxygenase-2 expression and its association with angiogenesis, Helicobacter pylori, and clinicopathologic characteristics of gastric carcinoma. Pathol Res Pract 204: 527-536, 2008.
19. Tatsuguchi A, Matsui K and Shinji Y: Cyclooxygenase-2 expression correlates with angiogenesis and apoptosis in gastric cancer tissue. Hum Pathol 35: 488-495, 2004.
20. Sun WH, Yu Q, Shen H, et al: Roles of Helicobacter pylori infection and cyclooxygenase-2 expression in gastric carcinogenesis. World J Gastroenterol 10: 2809-2813, 2004.
21. Wang BH, Qian W and Gao YJ: Effects of inhibition of cyclooxygenase-2 by RNA interference on proliferation and apoptosis of human gastric cancer cells: an experimental study with human gastric cancer cells and mice. Nat Med J China 86: 266-271, 2006.
22. Tjiu JW, Liao YH, Lin SJ, et al: Cyclooxygenase-2 over-expression in human basal cell carcinoma cell line increases antiapoptosis, angiogenesis, and tumorigenesis. J Invest Dermatol 126: 1143-1151, 2006.
23. Fosien E: Biochemistry of cyclooxygenase (COX-2) inhibitors and molecular pathology of COX-2 in neoplasia. Crit Rev Las Sci 37: 431-502, 2000.
24. Willams CS and DuBois RN: Prostaglandin endoperoxide synthase: why two isoforms? Am J Physiol 270: 393-400, 1996.
25. Konturek PC, Hartwich A, Zuchowicz M, et al: Helicobacter pylori, gastrin and cyclooxygenases in gastric cancer. J Physiol Pharmacol 51: 737-749, 2000.
26. Yu J, Leung WK, Chen J, Ebert MPA, Malfertheiner P and Sung JJY: Expression of peroxisome proliferators-activated receptor δ in human gastric cancer and its response to specific COX-2 inhibitor. Cancer Lett 223: 11-17, 2005.
27. Da MX, Wu XT, Wang J, et al: Expression of cyclooxygenase-2 and vascular endothelial growth factor-c correlates with lymph-angiogenesis and lymphatic invasion in human gastric cancer. Arch Med Res 39: 92-99, 2008.
28. Tegeder I, Pfeilschifter J and Geisslinger G: Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J 15: 2057-2072, 2001.
29. Yuan XL, Chen L, Li MX, et al: Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner. Clin Immunol 134: 277-288, 2010